Clinical trial
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric…
NCT00142350 · Japan Clinical Oncology Group, Other · Completed
Key facts
| NCT number | NCT00142350 |
|---|---|
| Title | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer |
| Official title | Randomized Phase III Study of 5-FU Continuous Infusion (5-FUci) Versus CPT-11 Plus CDDP (CP) Versus S-1 Alone (S-1) in Advanced Gastric Cancer (JCOG9912) |
| Lead sponsor | Japan Clinical Oncology Group, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan Taiho Pharmaceutical Co., Ltd. Industry Yakult Honsha Co., LTD |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | continuous infusion of 5-fluorouracil, combination of irinotecan and cisplatin, oral administration of S-1 |
| Enrollment | 690 |
| Start date | Nov 1, 2000 |
| Completion | Jan 1, 2007 |
| First posted | Sep 2, 2005 |
| Last update posted | Sep 12, 2016 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: